1. European Centre for Disease Prevention and Control. Bi-annual measles and rubella monitoring report, October 2017. Stockholm: ECDC; 2017. Available from: https://ecdc.europa.eu/sites/portal/files/documents/Biannual%20measles%20rubella%20monitoring-OCT-2017.pdf
2. Amendola A, Bubba L, Piralla A et al (2015) Surveillance and vaccination coverage of measles and rubella in Northern Italy. Hum VaccinImmunother 11(1):206–213
3. Perry RT, Halsey N (2004) The clinical significance of measles: a review. J Infect Dis 189(Suppl 1):S4–S16
4. Buchanan R, Bonthius DJ (2012 Sep) Measles virus and associated central nervous system sequelae. Semin Pediatr Neurol 19(3):107–114
5. Rafat C, Klouche K, Ricard JD, Messika J, Roch A, Machado S, Sonneville R, Guisset O, Pujol W, Guérin C, Teboul JL, Mrozek N, Darmon M, Chemouni F, Schmidt M, Mercier E, Dreyfuss D, Gaudry S (2013) Severe measles infection: the spectrum of disease in 36 critically ill adult patients. Medicine (Baltimore) 92:257–272